RD Lewis Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79M Sell
2,921
-30
-1% -$30.4K 2.42% 13
2025
Q4
$2.96M Buy
2,951
+79
+3% +$75.5K 2.53% 13
2025
Q3
$2.92M Buy
2,872
+211
+8% +$157K 2.74% 11
2025
Q2
$1.71M Sell
2,661
-5
-0.2% -$3.88K 1.72% 24
2025
Q1
$2.2M Buy
2,666
+121
+5% +$101K 2.49% 11
2024
Q4
$2.24M Buy
+2,545
New +$2.11M 2.46% 12

Other funds holding LLY

RD Lewis Holdings's LLY Position: Q1 2026 in Review

RD Lewis Holdings reduced its Eli Lilly (LLY) stake by 1% in Q1 2026, selling an estimated $30.4K and leaving 2,921 shares worth $2.79M. The position accounts for 2.42% of the portfolio, ranked #13.

RD Lewis Holdings first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.96M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • RD Lewis Holdings held 2,921 shares of Eli Lilly worth $2.79M as of Q1 2026.
  • RD Lewis Holdings sold 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
  • Eli Lilly made up 2.42% of RD Lewis Holdings's portfolio in Q1 2026, its #13 holding.
  • RD Lewis Holdings first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • RD Lewis Holdings's Eli Lilly position peaked at $2.96M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RD Lewis Holdings's 13F filing for Q1 2026, filed 14 Apr 2026.